HK

Haresh Kanubhai Vekariya

Active Director Director DIN 10426479
DIN 10426479 First appointment Dec 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Haresh Kanubhai Vekariya

Data last updated:

Haresh Kanubhai Vekariya is a Director at Medinoss Pharmaceutical Private Limited (since 2023). The company operates in Pharma.

DIN 10426479
Primary Designation Director
Industry Pharma
First Appointment 13 Dec 2023
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director13 Dec 20232023Active

Directorship timeline

Open interactive timeline →
Medinoss Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Haresh Kanubhai Vekariya

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Haresh Kanubhai Vekariya

Haresh Kanubhai Vekariya currently holds 1 directorship: Medinoss Pharmaceutical Private Limited (Director, since 13 Dec 2023).

Haresh Kanubhai Vekariya was first appointed on 13 Dec 2023 as Director at Medinoss Pharmaceutical Private Limited.

The current boards of Haresh Kanubhai Vekariya's companies include Hirenbhai Tejabhai Sabhaya (Medinoss Pharmaceutical Private Limited), Rohit Vinubhai Sukhadia (Medinoss Pharmaceutical Private Limited), Vimal Parbatbhai Gondaliya (Medinoss Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available